Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABAI-30 is a highly potent and orally bioavailable anti-inflammatory compound that efficiently suppresses nitric oxide (NO) production in lipopolysaccharide (LPS) activated RAW264.7 cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | ABAI-30 is a highly potent and orally bioavailable anti-inflammatory compound that efficiently suppresses nitric oxide (NO) production in lipopolysaccharide (LPS) activated RAW264.7 cells [1]. |
In vitro | In RAW264.7 cells, ABAI-30 at concentrations ranging from 10-40 µM suppresses the TLR4-pp65 and NLRP3-caspase-1 signaling pathways, resulting in the decreased expression of IL6, IL-1β, and TNFα at both the transcriptional and translational levels [1]. |
In vivo | In a mouse model of dextran sulfate sodium (DSS)-induced colitis, ABAI-30, administered orally at a dosage of 25 mg/kg for 5 days, exhibited significant in vivo anti-inflammatory effects with no evident toxicity [1]. |
Molecular Weight | 347.33 |
Formula | C17H13N7O2 |
CAS No. | 2757957-25-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABAI-30 2757957-25-6 inhibitor inhibit